2018
DOI: 10.1111/ceo.13388
|View full text |Cite
|
Sign up to set email alerts
|

Association of dyslipidaemia and oral statin use, and dry eye disease symptoms in the Blue Mountains Eye Study

Abstract: The association between oral statin use and presence of moderate to severe DED symptomatology is a novel finding that deserves further mechanistic and clinical correlation in order to determine its potential, or lack thereof, for the management of dry eye.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(16 citation statements)
references
References 24 publications
(41 reference statements)
0
15
0
Order By: Relevance
“…In contrast, the Australian Blue Mountains Eye Study III (BMES III) cohort study [ 41 ], a large population-based retrospective analysis consisting predominantly of Caucasian Australians aged over 59 years, showed that hypercholesterolemia—as well as serum LDL and HDL levels—had no significant association with DED symptoms, such as dryness, grittiness, itchiness, discomfort, or watering. However, oral statin therapy was associated with an increased risk of one or more moderate to severe symptoms of DED.…”
Section: Research Results From Previous Studiesmentioning
confidence: 99%
“…In contrast, the Australian Blue Mountains Eye Study III (BMES III) cohort study [ 41 ], a large population-based retrospective analysis consisting predominantly of Caucasian Australians aged over 59 years, showed that hypercholesterolemia—as well as serum LDL and HDL levels—had no significant association with DED symptoms, such as dryness, grittiness, itchiness, discomfort, or watering. However, oral statin therapy was associated with an increased risk of one or more moderate to severe symptoms of DED.…”
Section: Research Results From Previous Studiesmentioning
confidence: 99%
“…This could be related to the small sample size and the limited follow-up duration. A cross-sectional study from the Blue Mountains Eye study found that usage of statins was correlated with one or more symptoms of dry eye disease ( 12 ). However, this result is limited, as the study looked at symptoms of dry eye and lacked clinical examination results.…”
Section: Discussionmentioning
confidence: 99%
“…This raises the possibility that statins are able to directly affect lipid production in the eyelid and may decrease blepharitis risk. However, a prospective study in Taiwan found that statin use was unable to reverse lid margin meiboscores and meibum quality in patients with blepharitis, and the Blue Mountains Eye Study III showed the presence of dry eye symptoms with statin usage ( 12 , 13 ). However, a large, clinical study evaluating the role of statins in the prevention of blepharitis is lacking.…”
Section: Introductionmentioning
confidence: 99%
“…Dyslipidemia has been suggested to induce MGD, a major cause of DED [5,32]. However, oral statin therapy, not hypercholesterolemia, were recently reported to be associated with the symptoms of DED [33]. Interestingly, sterols have been reported to reduce cataract severity [34,35], and cholesterol metabolism might be linked to cataract formation [36].…”
Section: New Factors In Dry Eye Disease Modelmentioning
confidence: 99%